Stella Xu - 01 Jul 2021 Form 4/A - Amendment Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Director
Signature
/s/ Pierre Lorenzo (Attorney-in-Fact)
Issuer symbol
TPST
Transactions as of
01 Jul 2021
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 Sep 2021, 20:10:08 UTC
Date Of Original Report
06 Jul 2021
Previous filing
29 Jun 2021
Next filing
22 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +6,635 $0.000000 6,635 01 Jul 2021 Common Stock 6,635 $11.07 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over three (3) years, with one-third (1/3) of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.
F2 The reporting person holds these securities for the benefit of Quan Venture Fund I, L.P. ("Quan Capital"). The general partner of Quan Capital is Quan Venture Partners I, L.L.C. The reporting person is amanager of Quan Venture Partners I, L.L.C. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest. This report on Form 4 shall not be deemed anadmission the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Remarks:

The amended Form 4 is being filed to correct the vesting schedule of the option grant and to correct the price of the derivative security.